Xvivo Perfusion AB's total assets for Q4 2024 were kr2.40B, an increase of 5.47% from the previous quarter. XVIPF total liabilities were kr245.97M for the fiscal quarter, a 26.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.